2023/0491 - BRODALUMAB [210 MG/ 1.5 ML SOL INJ SERINGA]
TED · 635178-2026Award noticeawardedNo deadline given
Who already wins at this buyer
Firms with recorded awards from Unidade Local de Saúde Santa Maria, E.P.E. in this tender’s CPV categories — the incumbents you are bidding against.
| Firm | Wins | Awarded | Last win |
|---|---|---|---|
| ROCHE Farmacêutica Química, LDA | 26 | — | 2026-09-15 |
| GILEAD SCIENCES, LDA | 24 | — | 2026-09-15 |
| SANOFI-PRODUTOS FARMACÊUTICOS,LDA | 20 | €1,569,649 | 2026-09-15 |
| JANSSEN-CILAG FARMACEUTICA LDA | 15 | €371,730 | 2026-09-15 |
| NOVARTIS FARMA - PROD.FARM SA | 14 | — | 2026-09-08 |
Full buyer profile: what Unidade Local de Saúde Santa Maria, E.P.E. buys and who wins it →
CPV codes
33600000 Medical equipment & pharmaceuticalsDescription
BRODALUMAB [210 MG/ 1.5 ML SOL INJ SERINGA]
Similar tenders
Closest by meaning — across languages, via embeddings.
| Published | Title | Buyer | Match |
|---|---|---|---|
| 2026-09-15 | 2023/0491 - BRODALUMAB [210 MG/ 1.5 ML SOL INJ SERINGA] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 100% |
| 2026-06-09 | 2023/0491 - LANADELUMAB [300 MG/2 ML SOL INJ SERINGA] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 97% |
| 2026-06-02 | 2023/0491 - NIVOLUMAB [10 MG/ML 10 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-08-04 | 2023/0491 - NIVOLUMAB [10 MG/ML 10 ML SOL INJ FRS] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 96% |
| 2026-08-04 | 2023/0491 - SECUCINUMAB [300 MG/2 ML SOL INJ CANETA/ SERINGA] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 95% |
| 2026-06-09 | 2023/0491 - SECUCINUMAB [300 MG/2 ML SOL INJ CANETA/ SERINGA] | Unidade Local de Saúde Santa Maria, E.P.E. PT | 95% |